Launch your career in translational medicine with a two-year Erasmus Mundus Joint Master
The International Master in Innovative Medicine (IMIM) is a prestigious two-year programme coordinated by the University Medical Center Groningen (UMCG). IMIM trains the next generation of translational scientists, entrepreneurs, and innovators to work across disciplines, sectors, and countries.
Programme highlights
- Consortium: University of Groningen (Netherlands), Heidelberg University (Germany), University of Tartu (Estonia), and Uppsala University (Sweden)
- Double degree: Graduates receive degrees from two European institutions
- Global cohort: Students from around the world; associated academic partners in Brazil, Chile, Colombia, Mexico, and Japan
- Interdisciplinary training: Coursework, research, and “Bench to Bedside and Beyond” (BBB) projects connecting science, business, and entrepreneurship
- Funding: Erasmus Mundus scholarships available
What alumni say
“IMIM was enriching… it helped me clearly define my interests for the next step: a PhD.” — Alejandra Duque-Jaramillo (Colombia)
“An exchange at USP showed me translational oncology in action—patients benefiting directly from cutting-edge research. It deepened my sense of purpose and confirmed that biomedical research changes lives in real time.” — Maliká Dosmagambetova (Kazakhstan)
Key dates
- Applications open: October 2025
- Entry year: 2026–2027 academic year
Learn more & apply
Full programme details and application guidance: https://www.innovativemedicine.eu/
Photo by Matt Ridley on Unsplash